ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,439Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 68

$798K Total Retail Price of All Prescriptions

Rank: 6 out of 68

514 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

9% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 15,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 755 700 1 2
SIMVASTATIN 736 708 2 1
FUROSEMIDE 449 417 3 3
AMLODIPINE BESYLATE 442 431 4 7
OMEPRAZOLE 398 378 5 5
METFORMIN HCL 311 280 6 14
WARFARIN SODIUM 307 287 7 8
ATENOLOL 287 270 8 21
LISINOPRIL 275 256 9 4
METOPROLOL TARTRATE 244 233 10 6
GABAPENTIN 225 189 11 12
PRAVASTATIN SODIUM 223 219 12 29
GLYBURIDE 215 215 R 13 65
ENALAPRIL MALEATE 213 213 14 61
ATORVASTATIN CALCIUM 212 202 15 13
MIRTAZAPINE 205 205 16 15
HYDROCHLOROTHIAZIDE 196 193 17 11
TRAMADOL HCL 194 191 18 23
LOSARTAN POTASSIUM 179 176 19 37
GLIMEPIRIDE 175 171 20 69
TRIAMTERENE-HCTZ 168 130 21 67
LOVASTATIN 167 155 22 76
PANTOPRAZOLE SODIUM 166 143 23 30
DIOVAN 164 147 24 42
CITALOPRAM HBR 156 140 25 9
VERAPAMIL ER 154 151 26 142
DONEPEZIL HCL 152 152 27 10
TAMSULOSIN HCL 145 145 28 28
AZITHROMYCIN 144 136 29 97
HYDROCODONE-ACETAMINOPHEN 143 135 S3 30 17
FENTANYL 133 121 S2 31 39
METOPROLOL SUCCINATE 133 128 31 19
SERTRALINE HCL 131 113 33 20
PREDNISONE 131 127 33 47
JANUVIA 123 123 35 96
CLOPIDOGREL 121 118 36 31
ZETIA 120 116 37 110
GLIPIZIDE 118 106 38 54
MELOXICAM 110 110 39 111
KLOR-CON M20 108 107 40 40
CYMBALTA 107 99 41 59
IPRATROPIUM-ALBUTEROL 105 105 42 52
CARBIDOPA-LEVODOPA 105 105 42 50
PLAVIX 102 102 44 48
FLUTICASONE PROPIONATE 95 87 45 66
ADVAIR DISKUS 93 92 46 41
POLYETHYLENE GLYCOL 3350 93 90 46 22
TRAZODONE HCL 92 82 48 32
ESCITALOPRAM OXALATE 89 89 49 38
DIGOXIN 85 85 50 45
NITROFURANTOIN MONO-MACRO 84 83 51 140
ALLOPURINOL 83 83 52 46
ISOSORBIDE MONONITRATE ER 83 75 52 35
TRIAMTERENE-HYDROCHLOROTHIAZID 76 65 54 246
CYCLOBENZAPRINE HCL 73 61 R 55 162
PAROXETINE HCL 73 61 55 93
CELEBREX 72 72 57 112
RAMIPRIL 72 72 57 183
OXYBUTYNIN CHLORIDE 72 50 57 89
PROPRANOLOL HCL 71 71 60 172
FINASTERIDE 67 67 61 70
PROAIR HFA 67 67 61 169
BENAZEPRIL HCL 66 66 63 119
NEXIUM 64 64 64 62
MECLIZINE HCL 64 63 64 221
TRICOR 63 63 66 125
CARISOPRODOL 62 32 R 67 223
ZOLPIDEM TARTRATE 62 54 67 53
SYNTHROID 61 61 69 102
POTASSIUM CHLORIDE 59 55 70 18
TERAZOSIN HCL 58 58 71 170
NAMENDA 57 57 72 16
SPIRIVA 56 55 73 60
DILTIAZEM 24HR CD 54 42 74 86
LEVOFLOXACIN 53 51 75 91
LIPITOR 53 49 75 131
CARVEDILOL 53 53 75 27
CIPROFLOXACIN HCL 53 52 75 55
RISPERIDONE 52 48 79 25
OXYCONTIN 52 23 S2 79 92
DOXYCYCLINE HYCLATE 51 42 81 201
ALENDRONATE SODIUM 51 50 81 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 49 83 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.